Alison Joly
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 6
- TGF-β signaling in diseases 3
- Connective Tissue Growth Factor Research 3
- Oncology 5
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
- Co-authors
- Michelle Chen (3 shared papers)George F. Schreiner (5 shared papers)Judith A. Abraham (3 shared papers)Frauke Bentzien (3 shared papers)Stefan Engst (3 shared papers)F. Michael Yakes (3 shared papers)Peiwen Yu (3 shared papers)Andrew Lam (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemical Pharmacology (2 papers)Cancer Research (2 papers)Journal of Biological Chemistry (2 papers)Endocrinology (2 papers)
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Alison Joly
26 papers receiving 3.0k citations
Alison Joly's Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 380
- Oncology 803
- Cancer Research 367
- Molecular Biology 1.5k
- Pathology and Forensic Medicine 343
Countries citing papers authored by Alison Joly
This map shows the geographic impact of Alison Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Joly more than expected).
Fields of papers citing papers by Alison Joly
This network shows the impact of papers produced by Alison Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Joly. The network helps show where Alison Joly may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Joly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth Hit paper breakdown → | 2011 | 1078 |
| 2 | 2000 | 385 | |
| 3 | 2009 | 291 | |
| 4 | 1997 | 144 | |
| 5 | 2001 | 140 | |
| 6 | 1993 | 132 | |
| 7 | 2008 | 124 | |
| 8 | 1997 | 122 | |
| 9 | 2013 | 107 | |
| 10 | 2002 | 88 | |
| 11 | 2001 | 64 | |
| 12 | 1997 | 63 | |
| 13 | 2007 | 53 | |
| 14 | 1997 | 46 | |
| 15 | 1997 | 41 | |
| 16 | 1998 | 34 | |
| 17 | 2004 | 33 | |
| 18 | 1998 | 33 | |
| 19 | 2007 | 18 | |
| 20 | 1999 | 13 |
About Alison Joly
Alison Joly is a scholar working on Molecular Biology, Oncology, Cancer Research, Hepatology and Pathology and Forensic Medicine, having authored 26 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), NF-κB Signaling Pathways (5 papers), Liver physiology and pathology (4 papers), Connective tissue disorders research (3 papers), TGF-β signaling in diseases (3 papers), Connective Tissue Growth Factor Research (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Hepatology (380 citations), Oncology (803 citations), Cancer Research (367 citations), Molecular Biology (1.5k citations) and Pathology and Forensic Medicine (343 citations). Alison Joly has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Michelle Chen, George F. Schreiner, Judith A. Abraham, Frauke Bentzien, Stefan Engst, F. Michael Yakes, Peiwen Yu, Andrew Lam, Jenny Tan and Fawn Qian. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Cancer Research, Journal of Biological Chemistry and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.